RBC Capital Raises Equifax (EFX) Price Target to $189
Key Points
- The stock closed at $176.51 on October 26, 2026, and has recently traded around $176.32, about equal to its closing price.
- RBC Capital's $189 price target implies 7.19% upside from Equifax Inc.'s ($EFX) current $176.32 share price.
- Equifax has a market capitalization of approximately $21.4 billion and a P/E ratio of about 29.5.
Get Equifax text alerts
We text you when insiders, Congress, analysts or big funds move on $EFX.
By entering your mobile number and tapping the sign-up button, you provide express written consent to receive recurring automated text messages from TradeTexts at that number, including stock alerts about SEC filings, insider and congress trades, analyst ratings, hedge fund moves, and earnings results. Consent is not a condition of any purchase. Message frequency varies. Messages are not investment advice. Message and data rates may apply. Reply HELP for help and STOP to opt out at any time. See our Terms and Privacy Policy.
Not investment advice. TradeTexts is not a registered investment adviser, and this automated Equifax Inc. alert may contain errors. Disclosures
On October 26, 2026, RBC Capital downgraded Equifax Inc. (EFX) from Outperform to Sector Perform and set a new price target of $189, down from $177. This change reflects the firm's updated outlook on the company's performance based on its recent results.
RBC Capital's new target indicates a potential upside from the recent trading levels. The stock closed at $176.51 on the same day and was recently trading around $176.32, which is about equal to its closing price. The shares are currently below the 52-week high of $238.94, down about 26.2%, but above the 52-week low of $137.01, up about 28.7%.
EFX
Equifax Inc.
RBC Capital vs. the S&P 500
Hypothetical returns from RBC Capital's disclosed trades, not real profit or advice. How we model this.
Other Institutional Activity in Equifax Inc.
Several other institutional investors have also adjusted their positions in Equifax. Harris Associates L.P. trimmed its holdings by 82,070 shares, leaving it with about 7.4 million shares worth approximately $1.31 billion. In contrast, Capital International Investors increased its stake by 1,510,145 shares, bringing its total to about 5.2 million shares valued at around $915.6 million. Soroban Capital Partners LP added 226,382 shares, raising its total to about 4.4 million shares worth about $778.6 million. Meanwhile, Massachusetts Financial Services Co. reduced its position by 830,486 shares, ending with around 3.9 million shares valued at about $683 million.
Equifax Inc. Stock Down 5.8%
Equifax's stock is currently trading near its 50-day moving average of $166.96, about 5.6% above it. However, it is below its 200-day moving average of $177.99 by about 0.9%. The stock's recent performance shows it is below the mean price target of $198.40 set by analysts, indicating potential headwinds in meeting market expectations.
$EFX price target
Equifax Inc. daily closes and this analyst's $189 target. Not advice.
Recent Earnings
For the trailing twelve months, Equifax reported revenue of approximately $6.59 billion and an EPS of $6.18. The company has experienced a revenue growth of 9.6% year-over-year. Its next earnings report is scheduled for February 3, 2027, which will provide further insights into its financial health.
Earnings drift grade
Outlook vs expectations on the last report — not price action.
-
Forward outlook
3 target cuts vs 0 raises.
-
EPS & revenue
EPS beat estimates by 8.3%. Revenue beat estimates by 1.0%.
-
Profit surprise
EBITDA met by 2 percent. Operating income met by 1 percent.
-
Pre-earnings setup
Expectations were about average.
-
Analyst signal
3 target cuts.
-
Earnings quality
Gross margin down 1.0 points. Operating margin up 1.1 points. Positive free cash flow.
Earnings Call Summary
Equifax had a strong first quarter with revenue of $1.649 billion up 14 percent and earnings per share of $1.86 up 22 percent, both ahead of expectations. The big driver was U.S. mortgage revenue which jumped 38 percent, boosted by new Work Number Indicator products and strong mortgage activity in February before interest rates rose. Management is excited about their artificial intelligence driven products and record numbers of pending patents, but they are holding full year guidance steady due to concerns about the Iran conflict and rising interest rates dampening mortgage demand over the rest of the year.
Guidance Equifax reaffirmed its full year 2026 guidance of about $6.745 billion in revenue and $8.54 in earnings per share despite strong first quarter results. Management kept guidance steady because of economic uncertainty tied to the Iran conflict and interest rate volatility, which pressured mortgage volumes in March and April. They still expect mortgage revenue to grow over 20 percent for the full year and diversified markets to grow in the high single digits.
Very weak report. The release materially worsened the forward outlook.
Dividend
Equifax pays an annual dividend of $2.24 per share, which translates to a yield of about 1.23%. The company's dividend payout ratio stands at 35.3%, indicating a balanced approach to returning capital to shareholders while investing in growth.
Insider Buying and Selling at Equifax Inc.
Insider trading activity at Equifax shows several executives selling shares. John W. Gamble Jr., the Chief Operating Officer, sold 3,500 shares on May 1, 2026, at an average price of $176.54, totaling about $617,890. Chad M. Borton, an Officer, sold 2,455 shares on May 7, 2026, for about $426,900. CEO Mark W. Begor sold 37,791 shares on July 24, 2026, with a total value of approximately $6.51 million. Additionally, Gamble sold another 4,500 shares on September 3, 2026, at an average price of $187.96, totaling about $845,820.
Analysts Set New Price Targets
On October 26, 2026, RBC Capital downgraded Equifax to a Sector Perform rating and lowered its price target to $189. Prior to this, on October 21, 2026, BMO Capital maintained a Market Perform rating with a target of $175, while Stifel and Needham maintained Buy ratings with targets of $217 and $210, respectively. The consensus recommendation for Equifax is currently a Buy, with a mean price target of $198.40 based on 20 analyst opinions.
About Equifax Inc.
Equifax Inc. is a data and analytics company based in Atlanta, GA. It operates in three segments: Workforce Solutions, U.S. Information Solutions, and International, providing services that help businesses manage their data and analytics needs. The recent downgrade by RBC Capital highlights the firm's cautious stance on the company's near-term performance amidst evolving market conditions.
Bottom Line
Investors should keep an eye on Equifax's upcoming earnings report on February 3, 2027, for updates on its financial performance. The recent downgrade from RBC Capital may influence investor sentiment in the near term, as analysts reassess their expectations for the stock.
Related Filing Alerts
Source: RBC Capital's rating change on $EFX (Oct 26, 2026). Written by software, not financial advice. How we make alerts